Associate Director, Global RWE - Study Execution Lead

About this role

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function: Medical Affairs Group

Job Sub Function: Multi-Family Medical Affairs

Job Category: People Leader

All Job Posting Locations: Raritan, New Jersey, United States of America

Job Description: About Innovative Medicine   

Our   expertise   in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements.   Visionaries like you work on teams that save lives by developing the medicines of tomorrow.  

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.  

Learn more at   https://www.jnj.com/innovative-medicine  

An internal pre-identified candidate for consideration has been   identified . However, all applications will be considered.  

We are searching for the best talent for   an   Associate Director, Global RWE - Study Execution Lead  

Purpose:  

The Associate Director, Global Real-World Evidence (GRWE), Study Execution Lead (SEL) role is within the Global   Real World   Evidence (GRWE) team which sits in   Global   Commercial Strategy Office under Global Medical Affairs. This role reports to the Vice President, Global Real-World Evidence and serves as a key partner in translating strategy into execution.  

The SEL   is responsible for   operational leadership of the GRWE portfolio, ensuring studies are delivered on time, within budget, and to high-quality standards. The role   is responsible for   study operations, portfolio tracking, budget management, vendor oversight, and implementation of standardized processes that improve consistency, efficiency, and transparency across the GRWE organization. In   addition   the role will also support the scale-up of GRWE   CoE   capabilities by developing standardized research solutions, managing the internal analytics hub, and enhancing transparency through integrated project management and tracking.  

You will   be responsible for :  

• Serving as a key advisor/partner to the Vice President of GRWE and support the overall strategic and operational aspects and budget of the GRWE.  

• Partnering with the VP of GRWE and GRWE LT to develop and implement the GRWE vision, mission, strategic priorities, and operating framework, ensuring alignment with organizational   objectives   and future-state capabilities.  

• Partnering with GRWE leadership team on strategic initiatives to evolve the GRWE operating model, including governance structures, decision-making processes, ways of working, and cross-functional engagement models across Global, Regional, and Local organizations.  

• Streamline portfolio processes, including RW evidence gap identification, study prioritization, resource allocation, and investment planning as part of the WW IEGP process (in partnership with   TRex   Team).  

• Support development and execution of cross-therapeutic area RW evidence roadmaps that align evidence generation activities with key business, medical, market access, and adoption decisions throughout the product lifecycle.  

• Drive alignment across Medical Affairs, Market Access, Commercial, R&D, and Regional RWE teams to ensure coordinated RW Evidence planning and execution through the establishment of asset-specific GRWE Working Groups.  

• Work with Disease Leads across TAs to develop and   maintain   standardized RW evidence-generation frameworks, master protocols, protocol templates, and methodological toolkits to improve quality, consistency, and efficiency across GRWE studies.  

• Drive adoption of common study design standards, operational definitions, and analytical approaches across therapeutic areas and regions.  

• Support development of educational materials, training programs, and stakeholder engagement resources to enhance RWE literacy across functions and regions.  

• Create and maintain GRWE communication assets, including capability decks, playbooks, and evidence-generation guidance materials. Collaborate with Disease Leads across TAs to develop evidence synthesis packages and   disseminations   toolkits including WISE materials.  

Qualifications / Requirements:  

Key Requirements:  

• Advanced degree   required   (MS, MPH, PharmD, PhD, DrPH, or equivalent).  

• Minimum 3-5 years of program or project management experience within pharmaceuticals, biotechnology, healthcare, or related industries.  

• Experience managing clinical research, real-world evidence studies, or observational research programs.  

• Experience managing external vendors and research partners.  

• Strong project management, planning, and organizational skills.  

• Excellent written, verbal, and presentation communication skills.  

• Ability to manage multiple priorities in a fast-paced, matrixed environment.  

• Strong problem-solving, analytical, and stakeholder management skills.  

Preferred:  

• Experience supporting global evidence generation programs.  

• Experience implementing operational processes, standards, or continuous improvement initiatives.  

• Ability to work effectively across global, regional, and local teams.  

• Demonstrated ability to influence and bui

Similar jobs

• Associate Director, Global Health Economics & Outcomes Research (RWE) — Madrigalpharma · Remote
• Sr. Director, Epidemiology & RWE Analytics — Neurocrine · US CA San Diego
• Associate Director, MAA & RWE — Johnson & Johnson · Raritan, New Jersey, United States
• Director, Epidemiology & RWE Sciences — Ipsen · Cambridge (US)
• Senior Director, Regional Clinical Study Management — BeiGene · Remote
• Senior Director, RWE Lead in Inflammation Therapeutic Areas — Gilead Sciences · Foster City, California, United States | Parsippany, New Jersey, United States
• Associate Director, Global R&D Sourcing — BeiGene · Remote
• Director, Regional Clinical Study Management — BeiGene · Remote